The Latest Headlines at American Banking and Market News
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC lowered its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 36.5% in the fourth quarter, according to the company in its most recent filing with the Securities... More of this article »
Target Hospitality Corp. (NASDAQ:TH) Shares Sold by Los Angeles Capital Management LLC
Los Angeles Capital Management LLC cut its position in Target Hospitality Corp. (NASDAQ:TH – Free Report) by 16.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 110,952... More of this article »
Los Angeles Capital Management LLC Purchases 402,350 Shares of Babcock & Wilcox Enterprises, Inc. (NYSE:BW)
Los Angeles Capital Management LLC boosted its holdings in shares of Babcock & Wilcox Enterprises, Inc. (NYSE:BW – Free Report) by 116.9% during the 4th quarter, according to the company in its most recent disclosure with... More of this article »
Los Angeles Capital Management LLC Sells 6,730 Shares of Essential Properties Realty Trust, Inc. (NYSE:EPRT)
Los Angeles Capital Management LLC reduced its stake in shares of Essential Properties Realty Trust, Inc. (NYSE:EPRT – Free Report) by 13.7% during the 4th quarter, according to its most recent disclosure with the Securities... More of this article »
FMC (NYSE:FMC) PT Raised to $57.00
FMC (NYSE:FMC – Get Free Report) had its target price raised by equities researchers at Mizuho from $55.00 to $57.00 in a report released on Tuesday, Benzinga reports. The firm currently has a “neutral” rating on... More of this article »
Jackson Creek Investment Advisors LLC Has $448,000 Position in Alphabet Inc. (NASDAQ:GOOGL)
Jackson Creek Investment Advisors LLC reduced its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 16.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission... More of this article »
Alphabet Inc. (NASDAQ:GOOGL) Shares Sold by Compass Capital Management Inc.
Compass Capital Management Inc. cut its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC).... More of this article »
Brighton Jones LLC Buys 9,734 Shares of Alphabet Inc. (NASDAQ:GOOGL)
Brighton Jones LLC raised its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 9.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.... More of this article »
MONECO Advisors LLC Boosts Holdings in Alphabet Inc. (NASDAQ:GOOGL)
MONECO Advisors LLC grew its position in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 143.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The... More of this article »
Alpha Cubed Investments LLC Grows Stake in Alphabet Inc. (NASDAQ:GOOGL)
Alpha Cubed Investments LLC increased its stake in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 10.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned... More of this article »
Epic Trust Investment Advisors LLC Decreases Holdings in Alphabet Inc. (NASDAQ:GOOGL)
Epic Trust Investment Advisors LLC trimmed its position in shares of Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange... More of this article »
Pliant Therapeutics (NASDAQ:PLRX) Rating Reiterated by Needham & Company LLC
Pliant Therapeutics (NASDAQ:PLRX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a research note issued to investors on Tuesday, Benzinga... More of this article »
Jefferies Financial Group Reiterates Buy Rating for Pyxis Oncology (NASDAQ:PYXS)
Pyxis Oncology (NASDAQ:PYXS – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at Jefferies Financial Group in a note issued to investors on Tuesday, Marketbeat Ratings reports. They... More of this article »